Likewise, the ribonucleotide reductase regulatory subunit M2 (RRM2), frequently overexpressed in HCC tissues, promotes GSH biosynthesis via glutathione synthetase (GSS), thus protecting cells from ferroptosis and contributing to sorafenib resistance (132, 133). Here, RRM2 is linked to hepatocellular carcinoma.